BioLife Solutions, an established biotech firm, is poised to benefit from the booming cell and gene therapy sector, projected to grow significantly by 2030. Despite recent negative EPS, BioLife has ...
BioLife Solutions, Inc. is trading near 52-week lows as its growth story has floundered and profitability remains uncertain. The company offers bioproduction tools and services for the cell and gene ...
Chief Executive Officer and Chairman of the Board — Roderick de Greef Chief Financial Officer — Troy Wichterman Roderick de Greef: Thanks, Troy. Good afternoon, and thank you for joining us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback